Results 41 to 50 of about 4,233 (228)

S1 Guideline: Therapy of generalized pustular psoriasis

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary The S1 guideline “Therapy of generalized pustular psoriasis (GPP)” is a German guideline developed in accordance with the criteria of the AWMF. The full version addresses clinical presentation, pathogenesis, diagnosis and differential diagnosis, comorbidities, and therapy.
Rotraut Mößner   +17 more
wiley   +1 more source

Combination therapy cyclosporin A--PUVA in psoriasis

open access: yesActa Dermato-Venereologica, 1990
No abstract available.
M J, Korstanje, R F, Hulsmans
openaire   +2 more sources

Swiss Practice Recommendations for Chronic Prurigo Including Prurigo Nodularis

open access: yesInternational Journal of Dermatology, EarlyView.
Chronic prurigo, including prurigo nodularis, is a chronic, often treatment‐refractory condition characterized by persistent pruritus and chronic scratch lesions. Advances in the understanding of its underlying pathophysiology have enabled the development of novel targeted therapies; however, management remains challenging due to the expanding range of
Simon M. Mueller   +11 more
wiley   +1 more source

Methoxsalen-induced macular toxicity

open access: yesIndian Journal of Ophthalmology, 2017
Psoralen compounds such as methoxsalen are photosensitizer agents used in conjunction with ultraviolet A (UVA) radiation exposure as photochemotherapy (Psoralens and ultraviolet-A therapy [PUVA therapy]) for certain epidermal skin disorders such as ...
Aditya Maitray, Pukhraj Rishi
doaj   +1 more source

Tracing the Photoaddition of Pharmaceutical Psoralens to DNA

open access: yesMolecules, 2020
The psoralens 8-methoxypsoralen (8-MOP), 4,5′,8-trimethylpsoralen (TMP) and 5-methoxypsoralen (5-MOP) find clinical application in PUVA (psoralen + UVA) therapy. PUVA treats skin diseases like psoriasis and atopic eczema.
Janina Diekmann   +3 more
doaj   +1 more source

Multi‐omics profiling of chronic immune‐mediated skin diseases: SKINERGY protocol and strategic evaluation

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
The SKINERGY study will investigate six immune‐mediated inflammatory skin diseases through a nationwide collaboration across all Dutch university medical centres. Involving 720 patients and 120 healthy volunteers, it is aimed at generating a high‐quality dataset to identify biomarkers that enable personalized treatment strategies and improved disease ...
N. G. Koster   +68 more
wiley   +1 more source

Immune checkpoint inhibitor‐induced eosinophilic fasciitis: A pharmacovigilance and EADV Task force study

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
A comprehensive retrospective analysis of 121 immune checkpoint inhibitor‐induced eosinophilic fasciitis cases, including clinical presentation, diagnostic features and treatment outcomes using data from the EADV Task Force ‘Dermatology for Cancer Patients’, two international pharmacovigilance databases and the current literature.
Tristan V. M. Bruijn   +17 more
wiley   +1 more source

Effect of PUVA and UVB-311 nm therapy on the skin cytokine profile in patients with Mycosis fungoides

open access: green, 2021
А. А. Кубанов   +7 more
openalex   +3 more sources

Mogamulizumab as Bridge to Thiotepa‐Based Allogeneic Haematopoietic Stem Cell Transplantation in Sézary Syndrome: A Single‐Centre Experience

open access: yeseJHaem, Volume 7, Issue 3, June 2026.
ABSTRACT Introduction Sézary syndrome (SS) is an aggressive cutaneous T‐cell lymphoma for which allogeneic haematopoietic stem cell transplantation (allo‐HSCT) represents the only potentially curative treatment. Methods We report a single‐centre series of three consecutive SS patients treated with mogamulizumab as bridging therapy to allo‐HSCT using ...
Simone Maifredi   +11 more
wiley   +1 more source

Micose fungóide: estudo epidemiológico de 17 casos e avaliação da resposta terapêutica à PUVA Mycosis fungoides: epidemiologic study of 17 cases and evaluation of PUVA photochemotherapy

open access: yesAnais Brasileiros de Dermatologia, 2006
FUNDAMENTOS: A fotoquimioterapia com PUVA é indicada para tratamento da micose fungóide, empregada como monoterapia em estágios precoces ou combinada a outras drogas nos estágios mais avançados da doença.
Ida Duarte, Roberta Buense, Simone Aoki
doaj   +1 more source

Home - About - Disclaimer - Privacy